leadf
logo-loader
LSE:OKYO

Okyo Pharma Limited

Receive alerts
Market:
LSE
Market Cap:
£75.66 m
Price
11.25 GBX
Change
0.00%
52 weeks high
19.00
52 weeks low
0.78

In brief

OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc.

OKYO Pharma’s future strategy is to differentiate itself by focusing on opportunities where clinical development timelines are short. It is the intention that OKYO Pharma will work closely with its retained clinicians with a view to generating incremental value for its shareholders.

Snapshot

  • OKYO Pharma has two main products both targeting key cell receptors
  • Leading product in development treats dry eye syndrome
  • Second candidate is a potential non-opioid analgesic for treating chronic pain

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Are small-cap biotech stocks good investments now?

We look at the sector's success stories and assess what we can expect in the coming months

on 14/8/20